Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF and IL-1

By Haas M.J.   Horani M.   Mreyoud A.   Plummer B.   Wong N.C.W.   Mooradian A.D.  

Biochimica et Biophysica Acta (BBA)/General Subjects, Vol. 1623, Iss. 2, 2003-10 ,pp. : 120-128

Elsevier

Access to resources Recommend Favorite

Human CYP3A4-introduced HepG2 cells: In vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity

By Araki N.   Tsuruoka S.   Wang N.   Hasegawa G.   Yanagihara H.   Ando H.   Omasa T.   Enosawa S.   Nagai H.   Fujimura A.  

Xenobiotica, Vol. 38, Iss. 11, 2008-11 ,pp. : 1355-1364

Informa Healthcare

Access to resources Recommend Favorite

Comparison of metabolism-mediated effects of pyrrolizidine alkaloids in a HepG2/C3A cell-S9 co-incubation system and quantification of their glutathione conjugates

By Tamta Hemlata   Pawar Rahul S.   Wamer Wayne G.   Grundel Erich   Krynitsky Alexander J.   Rader Jeanne I.  

Xenobiotica, Vol. 42, Iss. 10, 2012-10 ,pp. : 1038-1048

Informa Healthcare

Access to resources Recommend Favorite

Performance of in vitro γH2AX assay in HepG2 cells to predict in vivo genotoxicity

By Tsamou Maria  

Mutagenesis, Vol. 27, Iss. 6, 2012-11 ,pp. : 645-652

Oxford University Press

Access to resources Recommend Favorite

Effects of Platelet-Activating Factor, Tumor Necrosis Factor, and Interleukin-1α on the Expression of Apolipoprotein M in HepG2 Cells

By Xu N.   Zhang X-Y.   Dong X.   Ekström U.   Ye Q.   Nilsson-Ehle P.  

Biochemical and Biophysical Research Communications, Vol. 292, Iss. 4, 2002-04 ,pp. : 944-950

Elsevier

Access to resources Recommend Favorite